Potential therapeutic target for melanoma identified
April 16th, 2009 - 2:15 pm ICT by ANIWashington, Apr 16 (ANI): Researchers at Albany Medical College claim to have identified a potential therapeutic target for melanoma.
The team led by Dr Andrew Aplin, an associate professor of Cancer Biology at Jefferson Medical College of Thomas Jefferson University, has discovered a protein called Mcl-1 that plays a critical role in melanoma cell resistance to a form of apoptosis called anoikis.
Mcl-1 is part of the Bcl-2 protein family, and is regulated by B-RAF proteins, which are mutated in approximately 60 percent of all human melanomas.
Aplin said that presence of Mcl-1 causes cell resistance to anoikis. This resistance to anoikis enables the melanoma cells to metastasize and survive at sites distant from the primary tumour.
During the study, the research team looked at three candidate Bcl-2 proteins: Mcl-1, Bcl-2 and Bcl-XL.
“When we depleted Mcl-1 from the tumour cells, they were susceptible to cell death,” said Aplin.
“Mcl-1 showed dramatic results compared to Bcl-2 and Bcl-XL, which was a surprise.
“Our findings show that targeting Mcl-1, which is upregulated in a majority of melanoma cells, could be a viable treatment strategy,” he added.
The study is published in Molecular Cancer Research. (ANI)
Related Stories
- Milk production hormone can help prevent aggressive breast cancer - Feb 04, 2010
- Novel therapeutic target for non-Hodgkin's lymphoma identified - Nov 23, 2009
- Scientists turn cancer cells'' bodyguard into their assassin - Nov 26, 2008
- How melanomas shield themselves from immune attack - Jan 13, 2010
- Researchers turn cancer friend into cancer foe - Oct 08, 2008
- Newly created peptide turns cancer friend into foe - Oct 08, 2008
- Soon, new compounds to sensitize cancerous tumors to therapy - Aug 06, 2009
- Cancer vaccines lead to long-term survival for skin cancer patients - Jul 29, 2009
- Nanoparticle containing drug that fights cancer genes developed - Sep 16, 2008
- Vegetable-based drug can inhibit melanoma: US researchers - Mar 02, 2009
- New targeted therapy delivers chemo directly to ovarian cancer cells - Jul 30, 2009
- Proteins key to melanoma development, treatment identified - May 07, 2008
- Novel drug raises hope for patients with advanced melanoma - Jun 02, 2009
- Laser therapy worsens skin cancer: Study - Nov 20, 2009
- Study sheds light on cancer cells affinity with sugar - Apr 16, 2008
- albany medical college
- anoikis
- bcl 2
- cancer biology
- cancer research
- cell death
- dr andrew
- dramatic results
- jefferson medical college
- jefferson medical college of thomas jefferson universit
- melanoma
- melanoma cells
- melanomas
- molecular cancer
- protein family
- therapeutic target
- thomas jefferson university
- treatment strategy
- tumour cells
- viable treatment
Posted in Health Science, |







